Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-09-15

Clinical Trial Update: Comparison of Nicotinamide Treatments for Actinic Keratosis [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial comparing nicotinamide treatments for actinic keratosis has completed. The study was sponsored by the Federal University of Rio Grande …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Nicotinamide (nicotinamide)

Snippet

Sponsor: Federal University of Rio Grande do Sul | Conditions: Actinic Keratoses | Phase 1 | Status: COMPLETED